Reducing addiction, promoting competition FDA priorities for 2018
The Food and Drug Administration today announced four priority areas for additional policy activity in 2018: reducing addiction to opioid drugs and cigarettes; promoting innovation and competition; empowering consumers to make informed decisions; and strengthening the FDA workforce. Specific policy efforts include new steps to support and streamline development and approval of treatments that address addiction; reducing burdens for creating and approving generic drugs; and extending new hiring and pay authorities to recruit and retain FDA staff.
Related News Articles
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
HHS awards $383 million in grants for suicide prevention, other behavioral health efforts on 988 Day
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…
Headline
The Department of Health and Human Services Aug. 17 announced that it will award $96.7 million in grants through the Substance Abuse and Mental Health Services…
Headline
The AHA’s Community Health Improvement network will host a webinar Aug. 26 at noon ET that will feature discussion from leaders at CredibleMind on what a…
Headline
The Health and Human Services Secretary July 29 announced that dozens of insurers, medical societies, healthcare providers and behavioral health…
Headline
The AHA’s Bridge to Care initiative highlights how hospitals and health systems are strengthening care transitions and supporting ongoing treatment engagement…